Protein secretion is conventionally viewed as taking place by either of two cellular routes, a regulated pathway, involving external stimuli and secretory granules, unda presumptive 'constitutive' pathway, which doesnot involve hormonal or neuronal stimuli or the production of secretory granules. The evidence reviewed here strongly suggests that there are post-synthesis rate-limiting steps for many proteins released by the ' constitutive' pathway and, hence, that regulation in some sense is involved here too. The nature of these rate-limiting determinants and events is discussed.
Introduction
The question posed in the title of this article implies a paradox. Indeed, it has been thought by some that proteins not packaged into secretory vesicles for later release or not directed to a specific intracellular organelle by some posttranslationally added signal (e.g. the mannose-6-phosphate modification of lysosomal enzymes) move through the cell via a continuous process that is essentially unregulated in the sense that it is passive and merely reflects 'bulk flow' of cellular material between intracellular compartments. Thus, in this view, the rate of secretion would be determined primarily by the rate of secretory protein synthesis. If this were the case, one would then expect that continuously secreted proteins, not stored in typical secretory vesicles for exocytosis in response to an external signal, would be secreted at the same or very similar rates as long as their biosynthetic rates were similar. We take the opposite point of view and will focus on the mechanisms of secretion of continuously secreted proteins and on potential mechanisms involved in regulation of their intracellular translocation and secretion.
Protein Secretory Pathways
Two general pathways are known to exist for the secretion of proteins from within the cell. The classic work of Palade and his colleagues' on the pancreatic acinar cell, in which zymogen is stored in secretory vesicles and dependent on stimuli for secretion, typifies one type of secretory pathway. Secretion from pancreatic acinar cells is regulated by neuronal or hormonal signals. This secretory process is defined by several discrete events: (1) synthesis in the rough endoplasmic reticulum (RER), (2) translocation from RER to Golgi, (3) sorting and segregation in the Golgi, (4) concentration and storage in secretory vesicles, ( 5 ) translocation to the cell surface and (6) secretion. The second step, translocation of protein from the rough endoplasmic reticulum to the Golgi apparatus, is energydependent. The third event is where secretory products are sorted into different pathways for export. The next step, in which condensing vacuoles, presumably generated from the Golgi membranes, become mature secretion vacuoles, is not dependent on energy, but is dependent on intracellular ionic gradients. The final step, secretion, requires both energy and Ca2+, is stimulated by depolarization events at the plasma membranes and can proceed in the absence of protein synthesis. This so-called 'regulated pathway' is found in specialized secretory cells, such as exocrine and endocrine cells, neurons, neutrophils, and mast cells.
A second secretory pathway is observed in some cells, including fibroblasts, chondrocytes, liver parenchymal cells, macrophages, and B lymphocytes. In these cells, the concentration step is omitted, secretory granules are not found, and intracellular storage of proteins is diminished or omitted. Ths type of secretion is said to be continuous or 'constitutive'. In contrast to the regulated secretory pathway, the rate of secretion by the constitutive pathway is not dependent on hormonal or neuronal stimulation, cytoplasmic cyclic nucleotide levels or, in most cases, the integrity of colchicine-and cytochalasin-sensitive structures such as microtubules and microfilaments. Table I . The mechanisms involved in the regulated pathway have been recently reviewed. 6 The observations that some cell types have both pathways, that the half-time for transport from the Golgi apparatus to the cell surface is long for proteins in the regulated pathways (q z 10 h)compared to those translocated to the cell surface by the constitutive pathway (ti z 10 min), and that some proteins are retained in organelles along the pathway (e.g. cytochrome P-450 in the RER), while others proceed through the cell into specific organelles (e.g. lysosomes, secretory vesicles) indicate that a ' sorting' mechanism exists in cells to direct translocated products into these different pathways. It should be noted that certain integral membrane proteins are also sorted and translocated to the cell surface via a constitutive mechanism that is similar to that of continuously secreted proteins.
For the regulated pathway, there is evidence to suggest that sorting occurs in the Golgi apparatus and that the molecular basis of this sorting depends on a 'sorting domain' of the secretory protein and on a 'carrier' that recognizes the sorting domain and directs the secretory protein into its correct secretory pathway. ' 6 An implication of this finding is that proteins secreted via the regulated pathway should have a shared sorting domain amino acid sequence that would be involved in their recognition of the carrier. No such common amino acid sequence has been found so far, but carrier recognition sequences may be analogous to the signal peptides of proteins synthesized in the RER for export; these signal peptides also lack a common primary amino acid sequence homology, yet recognize a common signal peptide recognition particle.
Based on a number of lines of evidence, it has been postulated that the regulated pathway has specific carriermediated intracellular translocation, whereas the constitutive pathway does not.6y8 The evidence is as follows. targeting information or carrier-mediated sorting. In this review, we would like to propose a different hypothesis, namely that the so-called constitutive pathway is in fact a regulated pathway, but that the regulation occurs at earlier steps in the intracellular translocation sequence than is the case for the 'regulated' pathway. It should be noted here that it' is likely that similar regulatory mechanisms occur in the pre-Golgi portions of both pathways and that the two pathways diverge in the Golgi.
Translocation from RER to
Golgi: Evidence for Regulated Steps in Continuously Secreting Cells
Fitting andKabatg analysed the synthesis and kinetics of intracellular transport of two Friend murine leukemia virus (MuLV) membrane glycoproteins in virally infected mouse cells. The two glycoproteins, gp 70 and gp 93, although synthesized at similar rates, reach the cell surface at different rates. Maximum incorporation of gp 93 into the plasma membrane occurs at 60 min after initiation of chase in a pulse-chase experiment albumin and a,-antitrypsin is secreted in 45 min after biosynthetic labelling; half of the labelled C3 complement component and a,-antichymotrypsin are released in 85-90 min, and half the labelled transferrin is secreted in 140min. The differences between the rates of secretion of these proteins appear to be due to the differences in rate of translocation from RER to Golgi, arguing against bulk flow between these two organelles and suggesting some selective, perhaps carrier-mediated event.
Ye0 et uL1, used cell fractionation techniques, lectin affinity, and sensitivity to the glycosidase endo H, which cleaves primarily the high mannose-containing oligosaccharides found in glycoproteins localized in the RER, to examine the rates of intracellular translocation and secretion of transferrin, ceruloplasmin, and a,-antitrypsin by cultured human hepatoma cells. These three substrates are secreted at very different rates, have different half-times for translocation from RER to Golgi and, in addition, have different apparent rates of translocation through the Golgi.
Peters et c~1 . l~. l3 have studied the rates of biosynthesis, processing, and secretion of chorionic gonadotropin (hCG) and laminin, two glycoproteins secreted continuously by cultured human choriocarcinoma (JAR) cells. Although the biosynthesis of these glycoproteins and the initial steps in their oligosaccharide processing occur at similar rates, their rates of release from the cell differ markedly. The half-time for release of hCG from JAR cells is 35 min and that of laminin 100 min. Based on determination of the oligosaccharide composition, the rate-limiting step in release of hCG and laminin is translocation from RER to Golgi.
The intracellular transport of two highly homologous class I histocompatibility antigens, H-2Kk and H-2Dk, has been determined in a murine B cell lymphoma cell line by Williams et ul.14 Newly synthesized H-2Kk reaches the cell surface within 1 h, whereas H-2Dk is transported much more slowly (tl = 4-5 h) to the cell surface. The rates of translocation to the cell surface of these two glycoproteins parallel the rates at which their asparagine-linked oligosaccharides are processed to endo H-resistance, suggesting that the ratelimiting step is transport from RER to Golgi.
Taken together, these data are incompatible with a passive, bulk flow model for continuously or constitutively secreted molecules and suggest some type of substrate-specific process that regulates the rate of their secretion. The concept that the secretion of these substrates is regulated only by their rate of biosynthesis is also excluded by the results cited above.
Characteristics of Substrate-Specific lntracellular

Trans1 ocat i o n Events
The rate-limiting event for a number of continuously secreted proteins appears to be translocation from RER to Golgi.
Lodish et d . 1° have postulated that a receptor protein in the RER membrane regulates selective accumulation of secretory proteins into transport vesicles en route to the Golgi. Faster-migrating proteins might have a higher affinity for this receptor than slowly migrating proteins. An alternative explanation is that each secretory protein has its own receptor, each of which has a characteristic rate of incorporation into a transport vesicle. The amount of receptor in the RER membrane could be determined by the rate of synthesis and turnover of the receptor, its rate of incorporation into the RER membrane and its ability to cluster in the 'budding' area of RER membrane involved in vesicle formation. There is a precedent for this latter suggestion in receptormediated endocytosis, where attachment of a ligand to its receptor mediates clustering or patching of the receptors in the plasma membrane prior to formation of the endocytic vesicle.1s
Recognition of such transport receptors could be via recognition signals determined by the polypeptide (either its primary amino acid sequence or conformation) or, in the case of glycoproteins, either by the polypeptide or by the oligosaccharide structure or both. There is evidence that both protein and carbohydrate structure may be involved in translocation events for secretory proteins. For example, mutant genes encoding viral membrane glycoproteins of Rous sarcoma virus (RSV) and of VSV that are missing various portions of the transmembrane and cytoplasmic domains (i.e. the part of the polypeptide on the cytoplasmic as opposed to the cisternal face of the RER) have been transfected into cells and translocation and secretion of their respective gene products studied.l6? l7 The RSV mutant glycoproteins lacking the transmembrane and the cytoplasmic domains and VSV glycoproteins lacking the cytoplasmic domain were retained in the RER and not translocated to the Golgi. These results suggest that the mutant proteins lack a translocating signal for transit to the Golgi. Studies with glycosidase inhibitors suggest that for certain glycoproteins translocation signals may involve the structure of their oligosaccharides. The use of glycoproteins to study translocation events has the advantage that the glycosidases and glycosyltransferase involved in their synthesis and processing are distinctly compartmentalized in the RER and Golgi apparatus (Fig. ]) .la Thus the oligosaccharide composition of cellular glycoproteins serves as a 20 Treatment of Hep G2 cells with the glucosidase inhibitor l-deoxynojirimycin blocks trimming of glucose residues from high-mannose oligosaccharides and inhibits translocation as well as secretion of or,-macroglobulin, ceruloplasmin, transferrin, and a,-antitrypsin by these cells but not translocation and secretion of albumin or VSV-G protein. The non-secreted glycoproteins accumulate in the RER, suggesting that trimming of the terminal glucose residues of N-linked oligosaccharides is a prerequisite for export of secretory glycoproteins from the RER. Similarly, the translocation of lysosomal enzymes cathepsin D and hexosaminidase from RER to Golgi is inhibited by 1 -deoxynojirimycin in cultured human diploid fibroblasts,
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The best case for the involvement of oligosaccharides in translocation events comes from lysosomal enzymes that require formation of 6-phosphomannosyl groups on their N-linked oligosaccharide chains for transport to the lysosomes. Treatment of fibroblasts, for example, with tunicamycin or I-deoxynojirimycin decreases the targeting of lysosomal hydrolases to lysosomes by preventing formation of the 6-phosphomannosyl group and causes their constitutive release from cells. 19 Taken together, these results indicate that N-linked oligosaccharides play an important regulatory role in the intracellular transport and secretion of glycoproteins and imply that a receptor or carrier invoked in the RER-Golgi translocation recognizes either the carbohydrate moiety itself or a conformational structure imposed on the glycoprotein by the presence of the oligosaccharide.
Role of Ionic Gradients in Translocation and Secretion
Agents that disrupt intracellular monovalent cation gradients in cells block intracellular translocation and secretion of a number of secretory proteins. For example, in a study of JAR choriocarcinoma cells, Peters et a1.22. 23 have shown that FCCP, methylamine, and monensin, three agents that collapse hydrogen ion gradients across cellular membranes by different mechanisms, inhibit oligosaccharide processing and secretion of hCG. FCCP and methylamine produce the accumulation of Man,_,GlcNAc, by JAR cells. The accumulation of these precursors indicates blockade of RER to Golgi translocation (Fig. 1) . On the other hand, monensin produces an intraGolgi blockade of translocation leading to the accumulation of Man,GlcNAc,-containing hCG subunits. CCCP, an analog of FCCP, also blocks RER-Golgi translocation of secretory proteins such as pancreatic z y m o g e n~,~~ collagen,25 immunoglobulin,, and thyroglobulin.26 Monensin has been shown to produce accumulation in the Golgi and to block secretion of a number of secretory proteins, including immunoglobulin,2 tran~ferrin,~~ fibronectin,28 procollagen,2B and viral membrane glyc~proteins.~' Although a number of these agents also lower cellular ATP levels, it has been shown that effects on secretion and oligosaccharide processing can be achieved at concentrations that do not significantly lower ATP.23. Thus, these results implicate an important role for hydrogen ion gradients in regulating intracellular translocation and secretion of proteins from cells.
Translocation from the Golgi to Plasma Membrane
It is this step that distinguishes most clearly the 'regulated' from the 'constitutive' secretory pathways. In the regulated pathway, the secretory products are stored in morphologically distinct secretory vesicles and are available for rapid release in response to an external signal. In the constitutive pathway, the translocation between Golgi and plasma membrane occurs continuously and relatively rapidly (ti z 10 min). Yet there must be some signals involved in the packaging of constitutively secreted products into vesicles and in the targeting of those vesicles to the appropriate place on the cell membrane where secretion can occur. Presumably this latter step involves a vesicle-plasma membrane fusion similar to that of the regulated pathway; however, as noted above, the constitutive pathway has several characteristics that distinguish it from the regulated type of exocytosis.
Although the most likely mechanism of transport of constitutively secreted Whether these putative post-Golgi transport vesicles are in fact the organelles that carry out the exocytotic event in the constitutive secretory pathway awaits further study.
Conclusion
In this review we have taken the point of view that several sites of regulation are present in the intracellular translocation and secretion events of the so-called constitutive secretory pathway. The rate-limiting event in this pathway appears to reside primarily at the RER-Golgi translocation step, and there is considerable circumstantial evidence to indicate that this is a carrieror ' receptor '-mediated event requiring some specific signal or signals in either the protein or the carbohydrate (or both) structure of the secretory products. Additional points of regulation may occur during the 'shuttle' of secretory proteins between the cis, medial, and trans compartments of the Golgi. The Golgi-plasma membrane step in the constitutive pathway has not been well characterized. It most likely occurs by vesicle-mediated transport, but these vesicles have not been clearly identified. At any rate, the steps involved in secretion in continuously secreting cells clearly are regulated events, and secretion via the 'constitutive' pathway depends on more than the rate of protein synthesis. Thus, in the broad sense, to call this an unregulated pathway is a misnomer. 
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General Features of spc DNA
Many eukaryotic cells have been shown to contain spc DNAs with a heterogeneous size distribution of from 0.1 to more than 2pm (6 kb).' Recently, a larger ill-defined population of spc DNA ranging in size to more than 150 kb has been isolated from mouse thymocytes.2 The common features of spc DNA populations are (1) chromosomal origin and (2) heterogeneity in size, total number per cell and nucleotide seq~ence.~ In mammalian cells, spc DNA was found in both fractions of karyoplasts and cyt~plasts.~ By these criteria, spc DNA can be distinguished from organelle DNAs, plasmids and viral DNAs.
Size Distribution and Copy
Number of spc DNA
Extrachromosomal circular DNAs may be present in the form of covalently closed circular (ccc) DNAs. However, the conventional method for isolating covalently closed circular (ccc) DNAs is a time-consuming and a large-scale process. Recent methodological developments involving mica-press-adsorption allowed rapid microscale visualization of spc DNAs and semi-quantitative measurements of the size distribution and the number per cell.'$4
Most, if not all, spc DNAs observed by the mica-press-adsorption method were attached to a bit of protein or to membrane fragments. The spc DNA thus examined may be linear with their two endslinked by proteins or membrane material and stabilized by forming a complex. Comparative studies on small circular DNAs isolated by different methods, the conventional dye-buoyantdensity method for authentic ccc DNA and the mica-press-adsorption method for the spc DNA/protein complex, were performed. The size distribution and the copy number of small circular DNAs estimated by these two different methods were very similar. Most spc DNA/proteincomplexes seem to represent authentic small circle^.^ Every eukaryotic cell studied so far has contained spc DNAs. Their size distribution and copy number are found to vary, depending on the cell source (Table 1) 
